Chinese mRNA COVID booster stronger against Omicron than Sinovac shot - Markets

Retrieved on: 2022-06-01 15:21:34

Tags for this article:

Clinical trials

RNA vaccines

Health

Vaccines

COVID-19 vaccination in the United States

Medical research

Science and technology in China

Walvax COVID-19 vaccine

Sinopharm

CanSino Biologics

Moderna COVID-19 vaccine

Pfizer-BioNTech COVID-19 vaccine

Walvax Biotechnology

China

Click the tags to see associated articles and topics

Chinese mRNA COVID booster stronger against Omicron than Sinovac shot - Markets. View article details on HISWAI: https://www.brecorder.com/news/40177135

Excerpt

BEIJING: A COVID-19 vaccine candidate from China's Walvax Biotechnology using mRNA technology triggered a stronger...

Article found on: www.brecorder.com

View Original Article